Healthcare Professionals
Affinity Pixie™
Oxygenation System
AFFINITY PIXIE™ OXYGENATION system
The Affinity Pixie™ Oxygenation System delivers performance and versatility for neonates, infants and small children requiring cardiopulmonary bypass at flow rates up to 2.0 L/minute. Its comprehensive system design offers ease of setup, ease of use, and minimised prime volumes.
The system features the Affinity Orbit™ Holder System, which provides even greater device positioning flexibility to adapt to your preferred circuit setup.
Two biocompatible surface options are provided for the oxygenator and cardiotomy/venous reservoir:
- Durable, Non-leaching End Point Attached Heparin
- Provides thromboresistance and enhanced blood compatibility
- A hydrophilic biosurface option without heparin
- Reduces platelet activation
- Reduces platelet adhesion
- Preserves platelet function1
AFFINITY PIXIE™ OXYGENATOR
Advanced Affinity™ Oxygenator Technology in a compact, low-prime design
This paediatric oxygenator features:
- 2.0 L/min maximum flow rate with just 48 mL prime
- The Medtronic proprietary graduated fiber bundle density technology, together with a radial-radial flow path, which create a uniform blood flow distribution through the bundle, enhance gas transfer, reduce pressure drop, and decrease fiber bundle prime volume
- Cortiva™ and Balance™ Biosurface*
- Device and accessories do not contain DEHP.
AFFINITY PIXIE™ CARDIOTOMY/VENOUS RESERVOIR
Ergonomic, easy-to-use design. Minimised blood contact with antifoam
This paediatric cardiotomy/venous reservoir features:
- 2.0 L/min maximum flow rate
- 1200 mL volume capacity
- 20 mL minimum operating volume without vortex formation
- Non-foaming blood does not contact antifoam at typical reservoir operating levels
- Independent rotation of venous inlet and cardiotomy turret
- Vacuum assisted venous drainage-ready design
- Cortiva™ and Balance™ Biosurface*
- Device and accessories do not contain DEHP.
HOLDERS FOR USE WITH THE AFFINITY PIXIE™ OXYGENATION SYSTEM
Affinity Orbit™ Holder System
Quick setup. Custom device positioning and orientation
- Quick and easy device attachment
- Adapts to any pump setup
- Versatile device positioning and port orientation
- Holder arm, oxygenator arm, and cardiotomy/venous reservoir pivot for custom device positioning
- Oxygenator rotates 360° for desired port orientation
- Facilitates reductions in circuit tubing length and associated prime volume
Affinity™ Manifold Holder
- Holds a standard flat-plate stopcock manifold in either horizontal or vertical orientation
- C-clamp for easy and stable attachment to both IV poles and larger diameter pump masts
Horizontal orientation
Vertical orientation
Caution: For a complete listing of indications, contraindications, precautions and warnings, please refer to the Instructions for Use which accompany each product.
ORDERING INFORMATION
OXYGENATION SYSTEMS
| Order Number | Description | # of Units |
|---|---|---|
| CBP211 | Hollow Fiber Oxygenator with Cortiva™ BioActive Surface | Tubing packs only |
| BBP211 | Hollow Fiber Oxygenator with Balance™ Biosurface | Tubing packs only |
| CBP241 | Hollow Fiber Oxygenator and Cardiotomy/Venous Reservoir with Cortiva BioActive Surface | Tubing packs only |
| BBP241 | Hollow Fiber Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface | 4 per case |
ACCESSORIES AND HOLDERS
| Order Number |
Description |
# of Units |
|---|---|---|
| ATP210 |
Affinity™ Temperature Probe |
1 per case |
| AUH2093 |
Affinity Orbit™ Holder System |
1 per case |
| AMH2014 |
Affinity™ Manifold Holder |
1 per case |
*
Balance™ is a registered trademark of Medtronic. Technology licensed under agreement from BioInteractions, Limited, United Kingdom.
References
1
See chart below.
Comparison between Balance-coated and uncoated in vitro bench test circuits of percentage of platelets that are activated with adenosine diphosphate (ADP @20 μM) in circulating heparinized human blood over time. Error bars represent standard deviation. († indicates p < 0.05)
Warnings: A strict anticoagulation protocol should be followed and anticoagulation should be routinely monitored during all procedures. The benefits of extracorporeal support must be weighed against the risk of systematic anticoagulation and must be assessed by the prescribing physician.
Caution: For a complete listing of indications, contraindications, precautions and warnings, please refer to the Instructions for Use which accompany each product.